Annex C change Sample Clauses

Annex C change. In accordance with article 17.1 of Agreement the parties agree that Section Annex C - Specification of payment amounts by distance is removed in its entirety. New 4. Změna přílohy C Smluvní strany se v souladu s čl. 17.1 Smlouvy dohodly na odstranění přílohy C – Stanovení proplácených náhrad wording about patient reimbursement is included in Annex B of this Amendment. podle vzdálenosti. Nové znění proplácení pacientských náhrad je uvedeno v příloze B tohoto dodatku. Expected value of this Amendment Agreement is CZK 2.829.524. Předpokládaná hodnota plnění této Smlouvy na základě tohoto Dodatku činí 2.829.524 Kč. The parties expressly agree, that changes in Annex B enter into force on the day of implementation of each Protocol Amendment on the site and effective on the day of publication in the Register of Contracts. Smluvní strany si tímto výslovně sjednávají, že změny v příloze B tohoto dodatku nabývají platnosti ke dni implementace jednotlivých dodatků protokolu na centru. Účinnosti pak dnem zveřejnění v registru smluv. All provisions of the Agreement not affected by this Amendment remain unchanged. Veškerá ustanovení Smlouvy, která nejsou tímto Dodatkem dotčena, zůstávají nezměněna. This Amendment is executed in Czech and English language version whereas the Czech version prevails. Tento Dodatek je vyhotoven v českém a anglickém jazykovém znění. V případě rozporu těchto verzí má přednost česká jazyková verze.
AutoNDA by SimpleDocs
Annex C change. The parties agree that Sect ion Annex C - Specificat ion of payment amounts by distance shall be replaced by the new wording which is annex of this Amendment due to new ICF version 4.0. 4. Změna přílohy C Smluvní strany se dohodly na novém znění přílohy B – Stanovení proplácených náhrad podle vzdálenosti, které je přílohou tohoto Dodatku a zcela nahrazuje dosavadní znění, z důvodu akutalizace ICF verze 4.0. Expected value CZK 683 152. of this amendment agreement is Předpokládaná hodnota plnění této smlouvy na základě tohoto dodatku činí 683 152 Kč. The parties expressly agree, that they wish to comply with this Amendment as of the date of approval of the Protocol Amendment No. 1 by St ate Institutte for Drug Cont rol and the relevant ethics committees. Sm luvní strany si t ímto výslovně sjednávají, že si přejí řídit se t ímto Dodatkem již ode dne schválení dodatku protokolu č. 1 St átním ústavem pro kontrolu léčiv a příslušnými etickými komisemi. IN W ITNESS W HEREOF, the parties hereto have caused this this Amendment to be executed in four original copies of which each Cont racting Party shall receive one original copy. Na důkaz toho se smluvní strany dohodly, že tento Dodatek bude vyhotoven ve t řech (3) vyhotoveních, z nichž každá ze smluvních stran obdrží po jednom (1) vyhotovení. Appendices: Annex A – Protocol of Clinical Trial included amendment (available from the Principal Investigator) Annex B – Budget & Payment Schedule Annex C - Specificat ion of payment amounts by distance Přílohy: Příloha A – Protokol včetně následného dodatku (dostupný u hlavního zkoušejícího) Příloha B – Rozpočet a rozpis plateb Příloha C - St anovení proplácených náhrad podle vzdálenosti On behalf of/ Za společnost Janssen - Cilag International N. V. Signat ure/ Podpis ______ ___________ ______ _ Janssen-Cilag s.r.o., Represented by Xxxxxxxxx Xxxxxxxx, M .D., Authorized Signat ory, GCO Count ry Head/ zastoupená M UDr. Xxxxxxxxxx Xxxxxxxxx prokuristkou, GCO Count ry Head Done at Prague date / Podepsáno v Praze dne 3. 8. 2021 Clinical Trial Agreement between Janssen and Institution and Principal InvestigatorCzech Republic contract template - Version October 2019 Smlouva o klinickém hodnocení mezi společností Janssen, poskytovatelem a hlavním zkoušejícím - vzor smlouvy pro Českou republiku – verze z října 2019 PI Name: Xxxxx xxxxxxxx zkoušejícího: ICD # 1491005 Protocol #: 67652000PCR3002 ICD # 1491005 Protokol č.: 67652000PCR3002 Signat ure/ Podpis _____ ______ _________ _...

Related to Annex C change

  • Schedule Change When a change of work schedule is requested by an employee and approved by the Agency, all forms of penalty pay shall be waived by the employee. When a change of work schedule is requested by an employee and approved by the Agency, overtime compensation for that workday, but not for work over forty (40) hours per week, associated with the changed schedule shall be waived.

  • Change of Control Defined For purposes of this this Note, the term “

  • Major Change For a major change referred to in paragraph (1)(a):

  • Change of Control Transaction If the Company or its successor terminates the Employment upon a merger, consolidation, or transfer or sale of all or substantially all of the assets of the Company with or to any other individual(s) or entity (the “Change of Control Transaction”), the Executive shall be entitled to the following severance payments and benefits upon such termination: (1) a lump sum cash payment equal to 12 months of the Executive’s base salary at a rate equal to the greater of his/her annual salary in effect immediate1y prior to the termination, or his/her then current annua1 salary as of the date of such termination; (2) a lump sum cash payment equal to a pro-rated amount of his/her target annual bonus for the year immediately preceding the termination; and (3) immediate vesting of 100% of the then-unvested portion of any outstanding equity awards held by the Executive.

  • Climate Change 1. The Parties recognize that the climate change and its adverse effects are a common concern. In that sense, and under their international commitments, the Parties agree to promote joint measures to limit or reduce the adverse effects of the climate change. 2. For promoting sustainable development, each Party, within its own capacities, shall adopt policies and measures on issues such as: (a) improvement of energy efficiency; (b) research, promotion, development and use of new and renewable energy, technologies of carbon dioxide capture, and updated and innovative environmental technologies that do not affect food security or the conservation of biological diversity; and (c) measures for evaluating the vulnerability and adaptation to climate change.

  • Major Workplace Change 11.1 If the Employer has made a decision to introduce a major workplace change that is likely to have a Significant Effect on a number of Employees, the Employer must notify the Employee(s) who will be affected by the decision .As soon as practicable and prior to implementation, the Employer must discuss with the relevant Employees and/or their nominated representative/s (e.g. Union or other representative) the introduction of the change; and the effect the change is likely to have on the Employees. The Employer must discuss measures to avert or mitigate the adverse effect of the change on the Employees. 11.2 For the purposes of the discussion the Employer will provide the relevant Employees and/or their nominated representative/s in writing: (a) All relevant information about the change including the nature of the change proposed; (b) Information about the expected effects of the change on the Employees; and (c) Any other matters likely to affect the Employees. However, the Employer is not required to disclose confidential or commercially sensitive information. The Employer must give prompt and genuine consideration to matters raised about the major change by the relevant Employees.

  • Change in Control Definition For purposes of this Agreement, “Change in Control” shall mean the occurrence of any of the following events, provided that such event or occurrence constitutes a change in the ownership or effective control of the Company, or a change in the ownership of a substantial portion of the assets of the Company, as defined in Treasury Regulation §§ 1.409A-3(i)(5)(v), (vi) and (vii): (i) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934 (the “Exchange Act”)) (a “Person”) of beneficial ownership of any capital stock of the Company if, after such acquisition, such Person beneficially owns (within the meaning of Rule 13d-3 under the Exchange Act) fifty percent (50%) or more of either (x) the then-outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (y) the combined voting power of the then-outstanding securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that for purposes of this subsection (i), the following acquisitions shall not constitute a Change in Control: (1) any acquisition directly from the Company or (2) any acquisition by any entity pursuant to a Business Combination (as defined below) which complies with clauses (x) and (y) of subsection (iii) of this definition; or (ii) a change in the composition of the Board that results in the Continuing Directors (as defined below) no longer constituting a majority of the Board (or, if applicable, the Board of Directors of a successor corporation to the Company), where the term “Continuing Director” means at any date a member of the Board (x) who was a member of the Board on the Effective Date or (y) who was nominated or elected subsequent to such date by at least a majority of the directors who were Continuing Directors at the time of such nomination or election or whose election to the Board was recommended or endorsed by at least a majority of the directors who were Continuing Directors at the time of such nomination or election; provided, however, that there shall be excluded from this clause (y) any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board; or (iii) the consummation of a merger, consolidation, reorganization, recapitalization or share exchange involving the Company, or a sale or other disposition of all or substantially all of the assets of the Company (a “Business Combination”), unless, immediately following such Business Combination, each of the following two (2) conditions is satisfied: (x) all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than fifty percent (50%) of the then-outstanding shares of common stock and the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors, respectively, of the resulting or acquiring corporation in such Business Combination (which shall include, without limitation, a corporation which as a result of such transaction owns the Company or substantially all of the Company’s assets either directly or through one (1) or more subsidiaries) (such resulting or acquiring corporation is referred to herein as the “Acquiring Corporation”) in substantially the same proportions as their ownership of the Outstanding Company Common Stock and Outstanding Company Voting Securities, respectively, immediately prior to such Business Combination and (y) no Person (excluding any employee benefit plan (or related trust) maintained or sponsored by the Company or by the Acquiring Corporation) beneficially owns, directly or indirectly, fifty percent (50%) or more of the then-outstanding shares of common stock of the Acquiring Corporation, or of the combined voting power of the then-outstanding securities of such corporation entitled to vote generally in the election of directors (except to the extent that such ownership existed prior to the Business Combination); or (iv) the liquidation or dissolution of the Company.

  • Shift Change Where employees are assigned mid-week to work a non-day shift (whether due to emergencies or a shift change) and as a result lose a shift in the regular work week, such employees will be paid six (6) hours for such loss of earnings.

  • Change in Control Defined For purposes of this Agreement, the term “Change in Control” shall mean the occurrence of any of the following events:

  • Status Change Upon the termination of the Optionee’s Employment, this Option shall continue or terminate, as and to the extent provided in the Plan and this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!